Danaher is meaningfully expanding its balance sheet and debt load ahead of its pending Masimo acquisition while simultaneously pulling back sharply on share repurchases.

The addition of Masimo Corporation as a named pending acquisition in the risk language — alongside debt that has grown 15.1% to $18.4B and rising interest expense of 35.5% — signals that capital allocation is shifting decisively toward M&A deployment rather than shareholder returns. The near-halving of share buybacks from $6.0B to $3.1B confirms management is conserving cash and balance sheet capacity for the deal, which investors should monitor closely for integration risk and leverage trajectory. The explicit new language around tariffs, healthcare policy uncertainty, and the 2025 U.S. administration change adds a layer of regulatory and macro risk that was not foregrounded in the prior filing.

Current assets grew notably from $9.5B to $12.8B (+34.3%), likely reflecting liquidity buildup in preparation for the Masimo transaction, while accounts receivable expanded modestly (+10.6%) to $3.9B. Total debt rose 15.1% to $18.4B, and interest expense increased meaningfully to $286M, reflecting the cost of carrying a larger debt load — a trend that could pressure net income if acquisitions do not integrate quickly. Share repurchases declined nearly by half to $3.1B while dividends grew modestly (+14.3% to $878M), painting a picture of a company deliberately redirecting free cash flow from buybacks toward strategic deployment, with rising financing costs as the near-term trade-off.

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.